Extraordinary General Shareholders’ Meeting 2020
Dear Shareholders,
The Extraordinary General Shareholders’ Meeting of Epigenomics AG has taken place on November 27, 2020 at 13:00 p.m. (CET) as a virtual event without the physical presence of the shareholders in Munich. The presence amounted to around 41% of the share capital. Shareholders approved all agenda items according to the Board’s proposal.
| Voting results of the Extraordinary General Shareholders’ Meeting 2020 (German only) | |
| Invitation to the Extraordinary General Shareholders’ Meeting 2020 of Epigenomics AG | |
| Letter to the Shareholders | |
| Report of the Executive Board on agenda item 2 | |
| Subscription and Backstop Agreement | |
| Annual Report 2019 (incl. Consolidated Financial Statements, Group Management Report, Supervisory Board Report, Key features of the internal control and risk management system and Remuneration Report) |
|
| Balance Sheet of Epigenomics AG (German HGB) as of September 30, 2020 (German only) | |
| Information on data protection | |
| Questions and answers | Link |
Corporate Governance/Declaration of Governance
| 2019 | |
| Declaration of Compliance with the German Corporate Governance Code pursuant to Section 161 of the German Stock Corporation Act (AktG) – October 2020 | |
| Declaration of Governance and reporting on Corporate Governance pursuant to Section 289a German Commercial Code (HGB) |
Further information
| Explanation of Shareholders’ rights | |
| Articles of Association |